Cumberland Pharmaceuticals Inc (NAS:CPIX)
$ 1.28 0.03 (2.4%) Market Cap: 18.04 Mil Enterprise Value: 21.85 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 51/100

Q2 2019 Cumberland Pharmaceuticals Inc Earnings Call Transcript

Aug 14, 2019 / 08:30PM GMT
Release Date Price: $5.55 (-3.31%)
Operator

Thank you for joining the Cumberland Pharmaceuticals Second Quarter 2019 Financial Report and Company Update Conference Call. Please be advised that this call is being recorded at the company's request, and it will be archived on Cumberland's website for 1 more -- for 1 week for today's -- from today's update.

Now I would like to introduce the host, Erin Gull, who handles Corporate Relations at Cumberland. Erin, please go ahead.

Erin Smith
Cumberland Pharmaceuticals Inc. - Senior Corporate Relations Associate

Good afternoon, everyone. Today, we issued a press release containing the company's financial results and corporate update for the second quarter ended June 30, 2019. That release is available on our website at www.cumberlandpharma.com.

And before we begin today's update, I'd like to review the following safe harbor language with you. Today's call may contain forward-looking statements within the meaning of the Private Securities Reform Act of 1995. Because the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot